Search Results 2341-2350 of 14734 for anti-TNF drugs

  1. Sulfur Hexafluoride Lipid Type A Microspheres (Injection Route, Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Carbonic Anhydrase Inhibitor (Oral Route, Parenteral Route) Proper Use - Mayo Clinic

    Ask your health care professional to help you plan the best time to take this medicine. Dosing. The dose medicines in this class will be different for different ...

  3. Mayo Clinic Cardiology Referral Program

    Similar to Mayo Clinic's Recognized Referral Facilitators, participants in the program provide to patients seeking treatment at Mayo Clinic previsit assistance ...

  4. Triamcinolone (Topical Application Route) Before Using - Mayo Clinic

    Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an ...

  5. Tafenoquine (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Back Pain Clinical Trials - Mayo Clinic Research

    We hypothesize that a device which measures compliance to physical therapy regimens in patients with low back pain will increase patient participation. Spinal ...

  7. Focus Areas - T Cell Engineering Laboratory - Mayo Clinic Research

    Kenderian, M.B., Ch.B., and his team is centered on the development and optimization of novel-engineered T cell therapy approaches for the treatment of cancer.

  8. Publications - Sabrina Sahni, M.D. - Mayo Clinic

    David PS, Sobel T, Sahni S, Mehta J, Kling JM. Menopausal Hormone Therapy in Older Women: Examining the Current Balance of Evidence. Drugs Aging. 2023 Aug ...

  9. Targeted Drug Can ‘Diminish the Suffering’ of Myelofibrosis - Mayo Clinic News Network

    CHICAGO — Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic ...

  10. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... anti-CD20 antibodies, BCL-2 inhibitors, and PI3k inhibitors.